Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ [Acta Pharmaceutica Sinica B 12 (2022) 1198–1212]

Detalles Bibliográficos
Autores principales: Wu, Yunhao, Yu, Xiu, Wang, Yuwei, Huang, Yalin, Tang, Jiahui, Gong, Shuaishuai, Jiang, Siyu, Xia, Yuanli, Li, Fang, Yu, Boyang, Zhang, Yuanyuan, Kou, Junping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293698/
https://www.ncbi.nlm.nih.gov/pubmed/35865100
http://dx.doi.org/10.1016/j.apsb.2022.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293698/
https://www.ncbi.nlm.nih.gov/pubmed/35865100
http://dx.doi.org/10.1016/j.apsb.2022.04.004

Ejemplares similares